

Industry
Biotechnology Research
Size
3001
Founded
2026
Headquarters
Minneapolis, Minnesota 55413, US
Type
Public Company
Followers
74.9K
Bio-Techne operates as a prominent entity within the biotechnology research sector, headquartered in Minneapolis, Minnesota. The organization functions as a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and precision diagnostics. With a workforce exceeding 3,000 individuals, the company maintains a significant international footprint through 34 locations worldwide. This extensive operational scale supports a catalog containing over 500,000 products designed to serve researchers and diagnostic professionals across various scientific disciplines.
Established in 1981 under the name R&D Systems, the firm rebranded to Bio-Techne in 2014. Strategic expansion has been driven by acquisitions, organic investments, and diversification into new markets, resulting in net sales surpassing $1.1 billion in fiscal year 2023. The company's portfolio encompasses a diverse range of specialized brands, including ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems, and Tocris Bioscience. These brands collectively provide the essential tools and solutions required for advancing biological research and diagnostic testing globally.
614 McKinley Place NE, Minneapolis, Minnesota 55413, US
Primary614 McKinley Place NE
Minneapolis, Minnesota 55413, US
Estimated ranges for roles at Bio-Techne will appear here as more data is available.
Bio-Techne is a 3001 Public Company in the Biotechnology Research industry, founded 2026, headquartered in Minneapolis, Minnesota 55413, US.
Bio-Techne operates as a prominent entity within the biotechnology research sector, headquartered in Minneapolis, Minnesota. The organization functions as a global developer, manufacturer, and supplier of high-quality reagents, analytical instruments, and precision diagnostics. With a workforce exceeding 3,000 individuals, the company maintains a significant international footprint through 34 locations worldwide. This extensive operational scale supports a catalog containing over 500,000 products designed to serve researchers and diagnostic professionals across various scientific disciplines.
Established in 1981 under the name R&D Systems, the firm rebranded to Bio-Techne in 2014. Strategic expansion has been driven by acquisitions, organic investments, and diversification into new markets, resulting in net sales surpassing $1.1 billion in fiscal year 2023. The company's portfolio encompasses a diverse range of specialized brands, including ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems, and Tocris Bioscience. These brands collectively provide the essential tools and solutions required for advancing biological research and diagnostic testing globally.
We’re syncing Bio-Techne’s live roles. Check back soon.